Fluvastatin Sodium Tablet, Extended Release shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting 2026-01-27 · last update 2026-01-27
Manufacturers: Sandoz Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/27/2026 Updated 01/27/2026 Discontinued 01/27/2026 |
| Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/27/2026 Updated 01/27/2026 Discontinued 01/27/2026 |
| Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/27/2026 Updated 01/27/2026 Discontinued 01/27/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)